These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 6928988)

  • 1. Socioeconomic status, urine estrogens, and breast cancer risk.
    Trichopoulos D; MacMahon B; Brown J
    J Natl Cancer Inst; 1980 Apr; 64(4):753-5. PubMed ID: 6928988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated urine estrogen and pregnanediol levels in daughters of breast cancer patients.
    Trichopoulos D; Brown JB; Garas J; Papaioannou A; MacMahon B
    J Natl Cancer Inst; 1981 Sep; 67(3):603-6. PubMed ID: 6944532
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogen profiles of primiparous and nulliparous women in Athens, Greece.
    Trichopoulos D; Cole P; Brown JB; Goldman MB; MacMahon B
    J Natl Cancer Inst; 1980 Jul; 65(1):43-6. PubMed ID: 6930516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urine estrogens, frequency of ovulation, and breast cancer risk: case-control study in premenopausal women.
    MacMahon B; Cole P; Brown JB; Paffenbarger R; Trichopoulos D; Yen S
    J Natl Cancer Inst; 1983 Feb; 70(2):247-50. PubMed ID: 6571932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estrogen profiles of premenopausal women with breast cancer.
    Cole P; Cramer D; Yen S; Paffenbarger R; MacMahon B; Brown J
    Cancer Res; 1978 Mar; 38(3):745-8. PubMed ID: 626978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between urine and plasma estrogen ratios.
    Longcope C; Pratt JH
    Cancer Res; 1978 Nov; 38(11 Pt 2):4025-8. PubMed ID: 698950
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma hormone profiles of young women at risk for familial breast cancer.
    Fishman J; Fukushima D; O'Connor J; Rosenfeld RS; Lynch HT; Lynch JF; Guirgis H; Maloney K
    Cancer Res; 1978 Nov; 38(11 Pt 2):4006-11. PubMed ID: 698948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormal estrogen conjugation in women at risk for familial breast cancer at the periovulatory stage of the menstrual cycle.
    Fishman J; Bradlow HL; Fukushima DK; O'Connor J; Rosenfeld RS; Graepel GJ; Elston R; Lynch H
    Cancer Res; 1983 Apr; 43(4):1884-90. PubMed ID: 6831424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary excretion of estrone, estradiol, and estriol in postmenopausal women with primary breast cancer.
    Morreal CE; Dao TL; Nemoto T; Lonergan PA
    J Natl Cancer Inst; 1979 Nov; 63(5):1171-4. PubMed ID: 291747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benign breast disease: estriol proportions and family history of breast cancer.
    Vakil DV; Morgan RW; Elinson L
    Cancer Detect Prev; 1981; 4(1-4):517-23. PubMed ID: 7349818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Hormonal correlations in hyperplasia of the breasts in women with ovulatory cycles].
    Mezinova NN; Iskakova KI; Bogdanova AG; Kozhnazarova IuS
    Vopr Onkol; 1975; 21(4):12-5. PubMed ID: 1198982
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous steroid hormone concentrations and risk of breast cancer among premenopausal women.
    Eliassen AH; Missmer SA; Tworoger SS; Spiegelman D; Barbieri RL; Dowsett M; Hankinson SE
    J Natl Cancer Inst; 2006 Oct; 98(19):1406-15. PubMed ID: 17018787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification and measurement of urinary estrone, estradiol-17 beta, estriol, pregnanediol and androsterone during the menstrual cycle of the orangutan.
    Collins DC; Graham CE; Preedy JR
    Endocrinology; 1975 Jan; 96(1):93-101. PubMed ID: 162882
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Urinary excretion of estrone glucosiduronate, 17 beta-estradiol-17-glucosiduronate, and estriol-16 alpha-glucosiduronate. Significance of proportionate differences during the menstrual cycle.
    Wright K; Collins DC; Preedy JR
    Steroids; 1979 Oct; 34(4):445-57. PubMed ID: 229588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oestrogen profiles of parous and nulliparous women.
    Cole P; MacMahon B; Brown JB
    Lancet; 1976 Sep; 2(7986):596-9. PubMed ID: 61341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urinary oestrogens and pregnandiol in breast cancer patients.
    Zaki K; El-Kharadly M; El-Faras A; Nour H; Kamel NI
    Endokrinologie; 1982 Feb; 79(1):49-56. PubMed ID: 7084131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of plasma and urinary sex hormone levels in premenopausal women over a one-year period.
    Michaud DS; Manson JE; Spiegelman D; Barbieri RL; Sepkovic DW; Bradlow HL; Hankinson SE
    Cancer Epidemiol Biomarkers Prev; 1999 Dec; 8(12):1059-64. PubMed ID: 10613337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urinary excretion of steroids by Japanese women with breast cancer.
    Tominaga T; Tei N; Kitamura M; Taguchi T; Kudo Y
    Gan; 1975 Jun; 66(3):305-10. PubMed ID: 1181230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Evaluation of the secretory activity of the adrenal cortex and gonads in women with epilepsy. II. Urinary excretion of estrogen fractions and alpha and beta pregnanediol during the 2 days preceding menstrual bleeding].
    Buntner B; Rościszewska D
    Neurol Neurochir Pol; 1985; 19(6):480-5. PubMed ID: 3835487
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of tamoxifen treatment on estrogen metabolism in postmenopausal women with advanced breast cancer.
    Levin J; Markham MJ; Greenwald ES; O'Connor JF; Zumoff B; Fukushima DK
    Anticancer Res; 1982; 2(6):377-80. PubMed ID: 7168557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.